TABLE 1.
General clinical information of patients in SR and ablation (total cohort).
| Variables | SR (n = 410) | Ablation (n = 391) | p value |
|---|---|---|---|
| Age (Year) | 51.8 ± 11.3 | 53.4 ± 11.1 | p = .046 |
| Sex (n,%) | p = .190 | ||
| Male | 355 (86.6) | 351(89.8) | |
| Female | 55 (13.4) | 40(10.2) | |
| Viral infections (n,%) | |||
| HBV | 384 (93.7) | 356 (91.0) | p < .001 |
| HCV | 3 (0.7) | 16 (4.1) | p < .001 |
| Cirrhosis (n,%) | 270 (65.9) | 265 (67.8) | p = .600 |
| Family History (n,%) | 25 (6.1) | 35 (9.0) | p = .140 |
| Combine chronic diseases (n,%) | 88 (21.5) | 80 (20.5) | p = .729 |
| BMI | 23.1 ± 3.3 | 22.8 ± 3.4 | p = .231 |
| WBC (×109/L) | 5.7 (2.4) | 5.1 (2.2) | p < .001 |
| Hb (g/L) | 142 (20) | 141 (23) | p = .149 |
| PLT (×109/L) | 166 (97) | 131 (89) | p < .001 |
| AST (U/L) | 31 (19) | 34 (28) | p = .010 |
| ALT (U/L) | 32 (25) | 35 (25) | p = .158 |
| ALB (g/L) | 41.30 (5.5) | 40.30 (6.8) | p = .020 |
| TBil (umol/L) | 12.90 (7.7) | 14.05 (11.0) | p < .001 |
| AFP (ng/ml) | 35.64 (337.5) | 23.86 (183.8) | p = .165 |
| Child‐Pugh classification (n,%) | p < .001 | ||
| A | 377 (92.0) | 317 (81.1) | |
| B | 33 (8.0) | 74 (18.9) | |
| Number of tumors (n,%) | p < .001 | ||
| Single | 397 (96.8) | 334 (85.4) | |
| Multiple | 13 (3.2) | 57 (14.6) | |
| Tumor diameter (mm) | 32 (21) | 20 (11) | p < .001 |
Abbreviations: AFP, alpha‐fetoprotein; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate transaminase; HBV, hepatitis B virus; HCV, hepatitis C virus; BMI, Body Mass Index; Hb, hemoglobin; PLT, platelet; SR, surgical resection; TBil, total bilirubin.